FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Donaghy Suzanne   2. Issuer Name and Ticker or Trading Symbol BARR PHARMACEUTICALS INC [BRL] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Sr Vice President/CIO (Last) (First) (Middle) BARR PHARMACEUTICALS, INC, 400 CHESTNUT RIDGE ROAD 3. Date of Earliest Transaction (Month/Day/Year) 01/06/2006 (Street) WOODCLIFF LAKE, NJ 07677 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 01/06/2006   X   16,168 A $ 10.0489 21,846 D   Common Stock 01/06/2006   X   3,943 A $ 11.0622 25,789 D   Common Stock 01/06/2006   X   3,750 A $ 24.5645 29,539 D   Common Stock 01/06/2006   X   5,000 A $ 35.01 34,539 D   Common Stock 01/06/2006   S   28,861 D $ 64.3496 5,678 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Incentive Stock Options

$ 10.0489

01/06/2006

X

4,922

09/09/1999

09/09/2008

Common Stock

4,922

$ 10.0489

98,437

D

Incentive Stock Options

$ 10.0489

01/06/2006

X

5,626

09/09/2000

09/09/2008

Common Stock

5,626

$ 10.0489

92,811

D

Incentive Stock Options

$ 10.0489

01/06/2006

X

5,620

09/09/2001

09/09/2008

Common Stock

5,620

$ 10.0489

87,191

D

Incentive Stock Options

$ 11.0622

01/06/2006

X

3,943

10/24/2001

08/11/2009

Common Stock

3,943

$ 11.0622

83,248

D

Non-Qualified Stock Options

$ 24.5645

01/06/2006

X

3,750

10/24/2001

08/09/2010

Common Stock

3,750

$ 24.5645

79,498

D

Non-Qualified Stock Options

$ 35.01

01/06/2006

X

5,000

08/04/2005

08/04/2014

Common Stock

5,000

$ 35.01

74,498

D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Donaghy Suzanne BARR PHARMACEUTICALS, INC 400 CHESTNUT RIDGE ROAD WOODCLIFF LAKE, NJ 07677			Sr Vice President/CIO

Signatures

S/S William T McKee as Attorney-in-Fact for Suzanne Donaghy		01/09/2006
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.